Lobbying Filing Details
Total Spending
$60,000
Activities
1
Lobbyists
2
Gov't Entities
2
Filing Information
- Filing UUID:
047beba8-87db-4b34-ab45-104d087af7e3- Type:
- Q1 - 1st Quarter - Report
- Period:
- 2026 - 1st Quarter (Jan 1 - Mar 31)
- Date Posted:
- April 20, 2026 at 6:35 PM
- Income:
- $60,000
- Expenses:
- $0
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Sarah Egge
Registrant
SPLITOAK STRATEGIES LLC
Health care consulting
Washington, District of ColumbiaClient
ALNYLAM PHARMACEUTICALS, INC.
Biopharmaceutical company
Massachusetts, United States of AmericaLobbying Activities (1)
Activity 1
Medicare/MedicaidRNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; H.R. 1672, Maintaining Investments in New Innovation Act; P.L. 119-21; U.S. Competitiveness
Lobbyists (2)
- AMY JENSEN
- SARAH KUEHL EGGE
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES